tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumCompany AnnouncementsRapport Therapeutics Completes Enrollment for Phase 2a Trial
2M ago
Premium
Company Announcements
Rapport Therapeutics Reports Q1 2025 Financial Results
2M ago
Premium
Ratings
Optimistic Buy Rating for Rapport Therapeutics Driven by Promising RAP-219 Developments
3M ago
Rapport Therapeutics initiated with an Outperform at Citizens JMP
PremiumThe FlyRapport Therapeutics initiated with an Outperform at Citizens JMP
4M ago
Rapport Therapeutics to present data at 2025 AAN meeting
Premium
The Fly
Rapport Therapeutics to present data at 2025 AAN meeting
4M ago
Premium
Ratings
Buy Rating Affirmed for Rapport Therapeutics Amid Promising RAP-219 Trials and Strong Financial Position
4M ago
Rapport Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyRapport Therapeutics Inc trading halted, volatility trading pause
5M ago
Premium
Company Announcements
Rapport Therapeutics Appoints New CMO Amid Phase 2a Updates
5M ago
Rapport Therapeutics appoints Sevigny as Chief Medical Officer
Premium
The Fly
Rapport Therapeutics appoints Sevigny as Chief Medical Officer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100